AI assistant
CD PRIVATE EQUITY FUND III — Fund Information / Factsheet 2021
Mar 11, 2021
64628_rns_2021-03-11_03dab12c-0260-4620-9df1-4517b2c51daf.pdf
Fund Information / Factsheet
Open in viewerOpens in your device viewer
Monthly update – February 2021
CD Private Equity Fund III
ASX release date: 12 March 2021
==> picture [457 x 52] intentionally omitted <==
----- Start of picture text ----- NTA Gross assets Distributions per unit One month Annualised performance sinceper unit (millions) (and percentage of inital investment) performance [1,2] inception (August 2012) [1,2]Last 12 months: Since inception:$1.63 $119.5 24 cents (15%) 25 cents (16%) -0.5% 4.3%----- End of picture text -----
Fund update
The estimated unaudited net tangible asset value (NTA) after tax as at 28 February 2021 was $1.63[1,3] per unit (31 January 2021 was $1.64[1] per unit).
As announced 29 January 2021, the Fund paid a distribution of 24 cents per unit to unitholders on 19 February 2021.
CD3 Fund performance
==> picture [456 x 39] intentionally omitted <==
----- Start of picture text ----- 1 Month 3 Months 6 Months 1 Year 3 Years p.a. 5 Years p.a. Since inception p.a. [3]NTA return [1,2] -0.5% -6.0% 8.7% -6.5% 8.4% – 4.3%----- End of picture text -----
On an NTA/Internal Rate of Return (IRR) basis CD3 has achieved a return of 4.6% per annum since inception.
CD3 portfolio asset allocation
LP commitments to underlying managers (US$117.5m)
==> picture [434 x 149] intentionally omitted <==
----- Start of picture text ----- Distribution Business BertramServices8.5% US Select $10.0 DFWII20.3% $27.5 $7.5 Elephant$5.0Software &Technology 26.4% $7.5 Encore10.1% ManufacturingTrive $10.0 $10.0 Gemspring$5.0$5.017.6% 17.1% Consumer & TelescopePeakSpan $5.0$10.0 $7.5 $7.5 InclineGrowth StreetHealthcare Retail NMS Luminate----- End of picture text -----
Level 15, 100 Pacific Highway North Sydney NSW 2060 T 1300 454 801 F 1300 883 159 E [email protected]
cdfunds.com.au ARSN 612 132 813